{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:57Z","timestamp":1792032957896,"version":"4.4.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10086-8","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:30:36Z","timestamp":1758875436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["METTL3-driven m\u2076A epigenetics in gastric cancer: unveiling oncogenic networks and clinical translation from tumorigenesis to therapy resistance"],"prefix":"10.1007","volume":"41","author":[{"given":"Xiaohong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-9251","authenticated-orcid":false,"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"10086_CR1","doi-asserted-by":"publisher","first-page":"116759","DOI":"10.1016\/j.bmc.2022.116759","volume":"64","author":"A Bajpai","year":"2022","unstructured":"Bajpai A, Deepshikha D, Chhabria T, Mishra SK, Basu S. Small molecule NSAID derivatives for impairing powerhouse in cancer cells. Bioorg Med Chem. 2022;64:116759. https:\/\/doi.org\/10.1016\/j.bmc.2022.116759.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10086_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1021\/acsbiomedchemau.3c00023","volume":"3","author":"RK Bedi","year":"2023","unstructured":"Bedi RK, Huang D, Li Y, Caflisch A. Structure-based design of inhibitors of the m(6)a-RNA writer enzyme METTL3. ACS Bio Med Chem Au. 2023;3(4):359\u201370. https:\/\/doi.org\/10.1021\/acsbiomedchemau.3c00023.","journal-title":"ACS Bio Med Chem Au"},{"key":"10086_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.935239","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Su X, Wang J, Zheng N, Tang Y, Peng G, et al. Identification and validation of METTL3-related molecules for predicting prognosis and efficacy of immunotherapy in gastric cancer based on m6A methylome and transcriptome sequencing analysis. Front Oncol. 2022;12:935239. https:\/\/doi.org\/10.3389\/fonc.2022.935239.","journal-title":"Front Oncol"},{"issue":"4","key":"10086_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/carcin\/bgad016","volume":"44","author":"W Chen","year":"2023","unstructured":"Chen W, He Q, Liu J, Li N, Xiao K, Chen H. PLAGL2 promotes snail expression and gastric cancer progression via UCA1\/miR-145-5p\/YTHDF1 axis. Carcinogenesis. 2023;44(4):328\u201340. https:\/\/doi.org\/10.1093\/carcin\/bgad016.","journal-title":"Carcinogenesis"},{"key":"10086_CR5","doi-asserted-by":"publisher","first-page":"1015293","DOI":"10.1155\/2021\/1015293","volume":"2021","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Gao S, Liang X, Lian C, Chen J, Fang C. Inhibiting PP2Acalpha promotes the malignant phenotype of gastric cancer cells through the ATM\/METTL3 Axis. Biomed Res Int. 2021;2021:1015293. https:\/\/doi.org\/10.1155\/2021\/1015293.","journal-title":"Biomed Res Int"},{"issue":"1","key":"10086_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327. https:\/\/doi.org\/10.1016\/j.cell.2012.06.013.","journal-title":"Cell"},{"issue":"1","key":"10086_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41420-023-01485-z","volume":"9","author":"SQ Ding","year":"2023","unstructured":"Ding SQ, Zhang XP, Pei JP, Bai X, Ma JJ, Zhang CD, et al. Role of N6-methyladenosine RNA modification in gastric cancer. Cell Death Discov. 2023;9(1):241. https:\/\/doi.org\/10.1038\/s41420-023-01485-z.","journal-title":"Cell Death Discov"},{"issue":"4","key":"10086_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17474124.2019.1573143","volume":"13","author":"R Fritsch","year":"2019","unstructured":"Fritsch R, Hoeppner J. Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma. Expert Rev Gastroenterol Hepatol. 2019;13(4):285\u201391. https:\/\/doi.org\/10.1080\/17474124.2019.1573143.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"10086_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/carcin\/bgac018","volume":"43","author":"Z Gao","year":"2022","unstructured":"Gao Z, Long Y, Wu Y, Pu Y, Xue F. LncRNA LINC02253 activates KRT18\/MAPK\/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer. Carcinogenesis. 2022;43(5):419\u201329. https:\/\/doi.org\/10.1093\/carcin\/bgac018.","journal-title":"Carcinogenesis"},{"key":"10086_CR10","doi-asserted-by":"publisher","first-page":"9822995","DOI":"10.1155\/2023\/9822995","volume":"2023","author":"Y Ge","year":"2023","unstructured":"Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, et al. The comprehensive analysis of N6-methyadenosine writer METTL3 and METTL14 in gastric cancer. J Oncol. 2023;2023:9822995. https:\/\/doi.org\/10.1155\/2023\/9822995.","journal-title":"J Oncol"},{"key":"10086_CR11","doi-asserted-by":"publisher","unstructured":"Gonzalez-Leal C, Cai J, Bafj de Groot Wegerer A, Preisser J, Luijsterburg MS, Ladurner AG. \"Poly-(ADP-ribose) serves as a scaffold for the methyltransferase METTL3\/14 complex in the DNA damage response.\" Nucleic Acids Res 2025;53(7). https:\/\/doi.org\/10.1093\/nar\/gkaf244.","DOI":"10.1093\/nar\/gkaf244"},{"issue":"1","key":"10086_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3.","journal-title":"J Hematol Oncol"},{"key":"10086_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142848","author":"A Gunes-Bayir","year":"2022","unstructured":"Gunes-Bayir A, Guler EM, Bilgin MG, Ergun IS, Kocyigit A, Dadak A. Anti-inflammatory and antioxidant effects of carvacrol on N-methyl-N\u2019-nitro-N-nitrosoguanidine (MNNG) induced gastric carcinogenesis in Wistar rats. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142848.","journal-title":"Nutrients"},{"issue":"8","key":"10086_CR14","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/ptr.7820","volume":"37","author":"P He","year":"2023","unstructured":"He P, He Y, Ma J, Liu Y, Liu C, Baoping Y, et al. Thymoquinone induces apoptosis and protective autophagy in gastric cancer cells by inhibiting the PI3K\/Akt\/mTOR pathway. Phytother Res. 2023;37(8):3467\u201380. https:\/\/doi.org\/10.1002\/ptr.7820.","journal-title":"Phytother Res"},{"issue":"11","key":"10086_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19(11):776\u2013800. https:\/\/doi.org\/10.1038\/s41573-020-0077-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10086_CR16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/curroncol29030131","volume":"29","author":"A H\u00f6gner","year":"2022","unstructured":"H\u00f6gner A, Moehler M. Immunotherapy in gastric cancer. Curr Oncol. 2022;29(3):1559\u201374. https:\/\/doi.org\/10.3390\/curroncol29030131.","journal-title":"Curr Oncol"},{"key":"10086_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, et al. New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76\u201383. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.008.","journal-title":"Chem Biol Interact"},{"issue":"11","key":"10086_CR18","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.7150\/jca.50403","volume":"12","author":"H Hu","year":"2021","unstructured":"Hu H, Kong Q, Huang XX, Zhang HR, Hu KF, Jing Y, et al. Longnon-coding RNA BLACAT2 promotes gastric cancer progression via the miR-193b-5p\/METTL3 pathway. J Cancer. 2021;12(11):3209\u201321. https:\/\/doi.org\/10.7150\/jca.50403.","journal-title":"J Cancer"},{"issue":"5\u20136","key":"10086_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/mutage\/gez041","volume":"34","author":"K Huebner","year":"2019","unstructured":"Huebner K, Proch\u00e1zka J, Monteiro AC, Mahadevan V, Schneider-Stock R. The activating transcription factor 2: an influencer of cancer progression. Mutagenesis. 2019;34(5\u20136):375\u201389. https:\/\/doi.org\/10.1093\/mutage\/gez041.","journal-title":"Mutagenesis"},{"issue":"16","key":"10086_CR20","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/s41388-021-01753-1","volume":"40","author":"FC Huo","year":"2021","unstructured":"Huo FC, Zhu ZM, Zhu WT, Du QY, Liang J, Mou J. METTL3-mediated m(6)a methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene. 2021;40(16):2968\u201381. https:\/\/doi.org\/10.1038\/s41388-021-01753-1.","journal-title":"Oncogene"},{"key":"10086_CR21","doi-asserted-by":"publisher","first-page":"394632023120469","DOI":"10.1177\/03946320231204694","volume":"37","author":"G Ji","year":"2023","unstructured":"Ji G, Wang X, Xi H. METTL3-mediated m(6)A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p\/cyclinD2 axis. Int J Immunopathol Pharmacol. 2023;37:3946320231204694. https:\/\/doi.org\/10.1177\/03946320231204694.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10086_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13046-022-02449-4","volume":"41","author":"Y Jia","year":"2022","unstructured":"Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, et al. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res. 2022;41(1):287. https:\/\/doi.org\/10.1186\/s13046-022-02449-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10086_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3892\/ol.2020.11794","volume":"20","author":"L Jiang","year":"2020","unstructured":"Jiang L, Chen T, Xiong L, Xu JH, Gong AY, Dai B, et al. Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation. Oncol Lett. 2020;20(3):2191\u20138. https:\/\/doi.org\/10.3892\/ol.2020.11794.","journal-title":"Oncol Lett"},{"issue":"6","key":"10086_CR24","doi-asserted-by":"publisher","first-page":"14595","DOI":"10.1080\/21655979.2022.2092674","volume":"13","author":"H Jin","year":"2022","unstructured":"Jin H, Wu Z, Tan B, Liu Z, Zu Z, Wu X, et al. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells. Bioengineered. 2022;13(6):14595\u2013604. https:\/\/doi.org\/10.1080\/21655979.2022.2092674.","journal-title":"Bioengineered"},{"issue":"9","key":"10086_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","volume":"17","author":"D Kabelitz","year":"2020","unstructured":"Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with \u03b3\u03b4 T cells: many paths ahead of us. Cell Mol Immunol. 2020;17(9):925\u201339. https:\/\/doi.org\/10.1038\/s41423-020-0504-x.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10086_CR26","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/21655979.2021.1909951","volume":"12","author":"J Kang","year":"2021","unstructured":"Kang J, Huang X, Dong WG, Zhu XY, Li M, Cui N. Microrna-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3). Bioengineered. 2021;12(1):1150\u201360. https:\/\/doi.org\/10.1080\/21655979.2021.1909951.","journal-title":"Bioengineered"},{"issue":"7964","key":"10086_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06102-8","volume":"618","author":"K Karlsson","year":"2023","unstructured":"Karlsson K, Przybilla MJ, Kotler E, Khan A, Xu H, Karagyozova K, et al. Deterministic evolution and stringent selection during preneoplasia. Nature. 2023;618(7964):383\u201393. https:\/\/doi.org\/10.1038\/s41586-023-06102-8.","journal-title":"Nature"},{"issue":"10","key":"10086_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.molcel.2023.04.018","volume":"83","author":"K Kawasaki","year":"2023","unstructured":"Kawasaki K, Fukaya T. Functional coordination between transcription factor clustering and gene activity. Mol Cell. 2023;83(10):1605-1622.e9. https:\/\/doi.org\/10.1016\/j.molcel.2023.04.018.","journal-title":"Mol Cell"},{"issue":"3\u20134","key":"10086_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13353-019-00516-9","volume":"60","author":"K Kiwerska","year":"2019","unstructured":"Kiwerska K, Szyfter K. DNA repair in cancer initiation, progression, and therapy-a double-edged sword. J Appl Genet. 2019;60(3\u20134):329\u201334. https:\/\/doi.org\/10.1007\/s13353-019-00516-9.","journal-title":"J Appl Genet"},{"issue":"3","key":"10086_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04129-0","volume":"79","author":"H Li","year":"2022","unstructured":"Li H, Wang C, Lan L, Yan L, Li W, Evans I, et al. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. Cell Mol Life Sci. 2022;79(3):135. https:\/\/doi.org\/10.1007\/s00018-022-04129-0.","journal-title":"Cell Mol Life Sci"},{"key":"10086_CR31","doi-asserted-by":"publisher","first-page":"1136096","DOI":"10.3389\/fcell.2023.1136096","volume":"11","author":"H Li","year":"2023","unstructured":"Li H, Lin J, Cheng S, Chi J, Luo J, Tang Y, et al. Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in Helicobacter pylori infection. Front Cell Dev Biol. 2023a;11:1136096. https:\/\/doi.org\/10.3389\/fcell.2023.1136096.","journal-title":"Front Cell Dev Biol"},{"key":"10086_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216410","volume":"576","author":"J Li","year":"2023","unstructured":"Li J, Feng H, Zhu J, Yang K, Zhang G, Gu Y, et al. Gastric cancer derived exosomal THBS1 enhanced V\u03b39V\u03b42 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner. Cancer Lett. 2023b;576:216410. https:\/\/doi.org\/10.1016\/j.canlet.2023.216410.","journal-title":"Cancer Lett"},{"key":"10086_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050796","author":"JJ Li","year":"2023","unstructured":"Li JJ, Rogers JE, Yamashita K, Waters RE, Blum Murphy M, Ajani JA. Therapeutic advances in the treatment of gastroesophageal cancers. Biomolecules. 2023c. https:\/\/doi.org\/10.3390\/biom13050796.","journal-title":"Biomolecules"},{"key":"10086_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00877-x","author":"R Li","year":"2023","unstructured":"Li R, Li Y, Wang Z, Suo R, Ma R, Zhang J. MiR-181-5p\/KLHL5 promoted proliferation and migration of gastric cancer through activating METTL3-mediated m6A process. Mol Biotechnol. 2023d. https:\/\/doi.org\/10.1007\/s12033-023-00877-x.","journal-title":"Mol Biotechnol"},{"key":"10086_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/med-2019-0005","volume":"14","author":"S Lin","year":"2019","unstructured":"Lin S, Liu J, Jiang W, Wang P, Sun C, Wang X, et al. METTL3 promotes the proliferation and mobility of gastric cancer cells. Open Med. 2019;14:25\u201331. https:\/\/doi.org\/10.1515\/med-2019-0005.","journal-title":"Open Med"},{"issue":"1","key":"10086_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jcp.28994","volume":"235","author":"T Liu","year":"2020","unstructured":"Liu T, Yang S, Sui J, Xu SY, Cheng YP, Shen B, et al. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. J Cell Physiol. 2020;235(1):548\u201362. https:\/\/doi.org\/10.1002\/jcp.28994.","journal-title":"J Cell Physiol"},{"issue":"3","key":"10086_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","volume":"29","author":"HT Liu","year":"2022","unstructured":"Liu HT, Zou YX, Zhu WJ, Liu S, Zhang GH, Ma RR, et al. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.\". Cell Death Differ. 2022;29(3):627\u201341. https:\/\/doi.org\/10.1038\/s41418-021-00879-9.","journal-title":"Cell Death Differ"},{"issue":"4","key":"10086_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cac2.12281","volume":"42","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhai E, Chen J, Qian Y, Zhao R, Ma Y, et al. M(6)a-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels. Cancer Commun. 2022b;42(4):327\u201344. https:\/\/doi.org\/10.1002\/cac2.12281.","journal-title":"Cancer Commun"},{"key":"10086_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11110944","author":"T Liu","year":"2023","unstructured":"Liu T, Feng Y, Yang S, Ge Y, Zhang T, Li J, et al. Depicting the profile of METTL3-mediated lncRNA m6A modification variants and identified SNHG7 as a prognostic indicator of MNNG-induced gastric cancer. Toxics. 2023. https:\/\/doi.org\/10.3390\/toxics11110944.","journal-title":"Toxics"},{"issue":"17","key":"10086_CR40","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v29.i17.2515","volume":"29","author":"T Matsuoka","year":"2023","unstructured":"Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol. 2023;29(17):2515\u201333. https:\/\/doi.org\/10.3748\/wjg.v29.i17.2515.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10086_CR41","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/ddr.22092","volume":"84","author":"H Meng","year":"2023","unstructured":"Meng H, Li J, Sun H, Lin Y, Xu H, Zhang N. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3\/cyclin D1 pathway. Drug Dev Res. 2023a;84(6):1325\u201334. https:\/\/doi.org\/10.1002\/ddr.22092.","journal-title":"Drug Dev Res"},{"issue":"13","key":"10086_CR42","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.18632\/aging.204836","volume":"15","author":"Q Meng","year":"2023","unstructured":"Meng Q, Schatten H, Zhou Q, Chen J. Crosstalk between m6A and coding\/non-coding RNA in cancer and detection methods of m6A modification residues. Aging (Albany NY). 2023b;15(13):6577\u2013619. https:\/\/doi.org\/10.18632\/aging.204836.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10086_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155\u20139. https:\/\/doi.org\/10.1038\/nrg2521.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"10086_CR44","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2022.02.007","volume":"185","author":"S Moshitch-Moshkovitz","year":"2022","unstructured":"Moshitch-Moshkovitz S, Dominissini D, Rechavi G. The epitranscriptome toolbox. Cell. 2022;185(5):764\u201376. https:\/\/doi.org\/10.1016\/j.cell.2022.02.007.","journal-title":"Cell"},{"key":"10086_CR45","unstructured":"NCT05168904. ClinicalTrials.gov; 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05168904"},{"issue":"3","key":"10086_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.gtc.2022.05.001","volume":"51","author":"DA Norwood","year":"2022","unstructured":"Norwood DA, Montalvan EE, Dominguez RL, Morgan DR. Gastric cancer: emerging trends in prevention, diagnosis, and treatment. Gastroenterol Clin North Am. 2022;51(3):501\u201318. https:\/\/doi.org\/10.1016\/j.gtc.2022.05.001.","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"10086_CR47","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.26355\/eurrev_202303_31793","volume":"27","author":"J Oh","year":"2023","unstructured":"Oh J, Oh JM, Cho SY. METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients. Eur Rev Med Pharmacol Sci. 2023;27(6):2561\u201370. https:\/\/doi.org\/10.26355\/eurrev_202303_31793.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10086_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/ol.2022.13651","volume":"25","author":"Y Okugawa","year":"2023","unstructured":"Okugawa Y, Toiyama Y, Yin C, Ruiya M, Goel A, Ichikawa T, et al. Prognostic potential of METTL3 expression in patients with gastric cancer. Oncol Lett. 2023;25(2):64. https:\/\/doi.org\/10.3892\/ol.2022.13651.","journal-title":"Oncol Lett"},{"key":"10086_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001657","author":"A Pemmari","year":"2021","unstructured":"Pemmari A, Tuure L, H\u00e4m\u00e4l\u00e4inen M, Lepp\u00e4nen T, Moilanen T, Moilanen E. Effects of ibuprofen on gene expression in chondrocytes from patients with osteoarthritis as determined by RNA-Seq. RMD Open. 2021. https:\/\/doi.org\/10.1136\/rmdopen-2021-001657.","journal-title":"RMD Open"},{"key":"10086_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115731","volume":"215","author":"JM Peng","year":"2023","unstructured":"Peng JM, Su YL. Lymph node metastasis and tumor-educated immune tolerance: potential therapeutic targets against distant metastasis. Biochem Pharmacol. 2023;215:115731. https:\/\/doi.org\/10.1016\/j.bcp.2023.115731.","journal-title":"Biochem Pharmacol"},{"key":"10086_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.996329","volume":"12","author":"G Peng","year":"2022","unstructured":"Peng G, Chen S, Zheng N, Tang Y, Su X, Wang J, et al. Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism. Front Oncol. 2022;12:996329. https:\/\/doi.org\/10.3389\/fonc.2022.996329.","journal-title":"Front Oncol"},{"key":"10086_CR52","doi-asserted-by":"publisher","first-page":"915837","DOI":"10.3389\/fimmu.2022.915837","volume":"13","author":"J Saura-Esteller","year":"2022","unstructured":"Saura-Esteller J, de Jong M, King LA, Ensing E, Winograd B, de Gruijl TD, et al. Gamma delta T-cell based cancer immunotherapy: past-present-future. Front Immunol. 2022;13:915837. https:\/\/doi.org\/10.3389\/fimmu.2022.915837.","journal-title":"Front Immunol"},{"issue":"10251","key":"10086_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5.","journal-title":"Lancet"},{"issue":"1","key":"10086_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","volume":"40","author":"C Song","year":"2021","unstructured":"Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis. J Exp Clin Cancer Res. 2021;40(1):62. https:\/\/doi.org\/10.1186\/s13046-021-01859-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10086_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040664","volume":"13","author":"X Su","year":"2023","unstructured":"Su X, Qu Yi, Mu D. The regulatory network of METTL3 in the nervous system: diagnostic biomarkers and therapeutic targets. Biomolecules. 2023;13(4):664.","journal-title":"Biomolecules"},{"issue":"5","key":"10086_CR56","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.21037\/tlcr-24-85","volume":"13","author":"X Su","year":"2024","unstructured":"Su X, Feng Y, Qu Y, Mu D. Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications. Transl Lung Cancer Res. 2024a;13(5):1121\u201336. https:\/\/doi.org\/10.21037\/tlcr-24-85.","journal-title":"Transl Lung Cancer Res"},{"key":"10086_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116157","volume":"172","author":"X Su","year":"2024","unstructured":"Su X, Lu R, Qu Y, Mu D. Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases. Biomed Pharmacother. 2024b;172:116157. https:\/\/doi.org\/10.1016\/j.biopha.2024.116157.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10086_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18128","volume":"28","author":"X Su","year":"2024","unstructured":"Su X, Lu R, Qu Y, Mu D. Methyltransferase-like 3 mediated RNA m(6)a modifications in the reproductive system: potentials for diagnosis and therapy. J Cell Mol Med. 2024c;28(4):e18128. https:\/\/doi.org\/10.1111\/jcmm.18128.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10086_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.167010","volume":"1870","author":"X Su","year":"2024","unstructured":"Su X, Qu Y, Mu D. Methyltransferase-like 3 modifications of RNAs: implications for the pathology in the endocrine system. Biochim Biophys Acta Mol Basis Dis. 2024d;1870(3):167010. https:\/\/doi.org\/10.1016\/j.bbadis.2023.167010.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"10086_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.21037\/tlcr-24-85","volume":"13","author":"X Su","year":"2024","unstructured":"Su X, Feng Yi, Qu Yi, Mu D. Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications. Transl Lung Cancer Res. 2024e;13(5):1121\u201336.","journal-title":"Transl Lung Cancer Res"},{"key":"10086_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110504","volume":"129","author":"J Sun","year":"2020","unstructured":"Sun J, Zheng Y, Mamun M, Li X, Chen X, Gao Y. Research progress of PD-1\/PD-L1 immunotherapy in gastrointestinal tumors. Biomed Pharmacother. 2020a;129:110504. https:\/\/doi.org\/10.1016\/j.biopha.2020.110504.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10086_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03049-w","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li S, Yu W, Zhao Z, Gao J, Chen C, et al. N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN\/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death Dis. 2020b;11(10):836. https:\/\/doi.org\/10.1038\/s41419-020-03049-w.","journal-title":"Cell Death Dis"},{"key":"10086_CR63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymeth.2021.03.004","volume":"196","author":"T Tagawa","year":"2021","unstructured":"Tagawa T, Kopard\u00e9 VN, Ziegelbauer JM. Identifying and characterizing virus-encoded circular RNAs. Methods. 2021;196:129\u201337. https:\/\/doi.org\/10.1016\/j.ymeth.2021.03.004.","journal-title":"Methods"},{"issue":"7","key":"10086_CR64","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)a modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69(7):1193\u2013205. https:\/\/doi.org\/10.1136\/gutjnl-2019-319639.","journal-title":"Gut"},{"issue":"2","key":"10086_CR65","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1080\/21655979.2021.1983276","volume":"12","author":"GP Wang","year":"2021","unstructured":"Wang GP, Zhang ZC, Xia CM. Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p\/METTL3 axis. Bioengineered. 2021;12(2):9678\u201391. https:\/\/doi.org\/10.1080\/21655979.2021.1983276.","journal-title":"Bioengineered"},{"key":"10086_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.861807","volume":"12","author":"N Wang","year":"2022","unstructured":"Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X, et al. METTL3-mediated ADAMTS9 suppression facilitates angiogenesis and carcinogenesis in gastric cancer. Front Oncol. 2022a;12:861807. https:\/\/doi.org\/10.3389\/fonc.2022.861807.","journal-title":"Front Oncol"},{"issue":"28","key":"10086_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201889","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, et al. APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly. Adv Sci. 2022b;9(28):e2201889. https:\/\/doi.org\/10.1002\/advs.202201889.","journal-title":"Adv Sci"},{"issue":"1","key":"10086_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01576-6","volume":"20","author":"R Wang","year":"2022","unstructured":"Wang R, Ha KY, Dhandapani S, Kim YJ. Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K\/Akt\/mTOR signaling pathway. J Nanobiotechnology. 2022c;20(1):441. https:\/\/doi.org\/10.1186\/s12951-022-01576-6.","journal-title":"J Nanobiotechnology"},{"key":"10086_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1257410","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hong Z, Song J, Zhong P, Lin L. METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway. Front Pharmacol. 2023;14:1257410. https:\/\/doi.org\/10.3389\/fphar.2023.1257410.","journal-title":"Front Pharmacol"},{"issue":"8","key":"10086_CR70","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41556-022-00968-y","volume":"24","author":"X Wei","year":"2022","unstructured":"Wei X, Huo Y, Pi J, Gao Y, Rao S, He M, et al. METTL3 preferentially enhances non-m(6)A translation of epigenetic factors and promotes tumourigenesis. Nat Cell Biol. 2022;24(8):1278\u201390. https:\/\/doi.org\/10.1038\/s41556-022-00968-y.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10086_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12964-023-01385-w","volume":"21","author":"T Wen","year":"2023","unstructured":"Wen T, Li T, Xu Y, Zhang Y, Pan H, Wang Y. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing. Cell Commun Signal. 2023;21(1):355. https:\/\/doi.org\/10.1186\/s12964-023-01385-w.","journal-title":"Cell Commun Signal"},{"key":"10086_CR72","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.2147\/Cmar.S245019","volume":"12","author":"TL Xia","year":"2020","unstructured":"Xia TL, Yan SM, Yuan L, Zeng MS. Upregulation of METTL3 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Manag Res. 2020;12:5729\u201337. https:\/\/doi.org\/10.2147\/Cmar.S245019.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10086_CR73","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ddr.21650","volume":"81","author":"F Xiao","year":"2020","unstructured":"Xiao F, Ouyang B, Zou J, Yang Y, Yi L, Yan H. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK\/mTOR pathway. Drug Dev Res. 2020;81(5):544\u201350. https:\/\/doi.org\/10.1002\/ddr.21650.","journal-title":"Drug Dev Res"},{"issue":"1","key":"10086_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01223-4","volume":"19","author":"JW Xie","year":"2020","unstructured":"Xie JW, Huang XB, Chen QY, Ma YB, Zhao YJ, Liu LC, et al. M(6)a modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. Mol Cancer. 2020;19(1):114. https:\/\/doi.org\/10.1186\/s12943-020-01223-4.","journal-title":"Mol Cancer"},{"key":"10086_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114118","volume":"230","author":"P Xu","year":"2022","unstructured":"Xu P, Ge R. Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy. Eur J Med Chem. 2022;230:114118. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114118.","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10086_CR76","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41419-022-05132-w","volume":"13","author":"W Xu","year":"2022","unstructured":"Xu W, Lai Y, Pan Y, Tan M, Ma Y, Sheng H, et al. M6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer. Cell Death Dis. 2022a;13(8):715. https:\/\/doi.org\/10.1038\/s41419-022-05132-w.","journal-title":"Cell Death Dis"},{"key":"10086_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.970367","volume":"12","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen Q, Shu L, Zhang C, Liu W, Wang P. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer. Front Oncol. 2022b;12:970367. https:\/\/doi.org\/10.3389\/fonc.2022.970367.","journal-title":"Front Oncol"},{"issue":"4","key":"10086_CR78","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbrc.2019.11.016","volume":"521","author":"JJ Yan","year":"2020","unstructured":"Yan JJ, Huang XF, Zhang XJ, Chen ZJ, Ye C, Xiang WC, et al. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells. Biochem Biophys Res Commun. 2020;521(4):887\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.016.","journal-title":"Biochem Biophys Res Commun"},{"key":"10086_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00115","volume":"10","author":"DD Yang","year":"2020","unstructured":"Yang DD, Chen ZH, Yu K, Lu JH, Wu QN, Wang Y, et al. METTL3 promotes the progression of gastric cancer via targeting the MYC pathway. Front Oncol. 2020a;10:115. https:\/\/doi.org\/10.3389\/fonc.2020.00115.","journal-title":"Front Oncol"},{"issue":"24","key":"10086_CR80","doi-asserted-by":"publisher","first-page":"24967","DOI":"10.18632\/aging.103767","volume":"12","author":"Z Yang","year":"2020","unstructured":"Yang Z, Jiang X, Li D, Jiang X. Hbxip promotes gastric cancer via METTL3-mediated MYC mRNA m6a modification. Aging (Albany NY). 2020b;12(24):24967\u201382. https:\/\/doi.org\/10.18632\/aging.103767.","journal-title":"Aging (Albany NY)"},{"key":"10086_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216092","volume":"558","author":"J Yang","year":"2023","unstructured":"Yang J, Xu P, Chen Z, Zhang X, Xia Y, Fang L, et al. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer. Cancer Lett. 2023;558:216092. https:\/\/doi.org\/10.1016\/j.canlet.2023.216092.","journal-title":"Cancer Lett"},{"issue":"7","key":"10086_CR82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10(7):627\u201342. https:\/\/doi.org\/10.1016\/j.trecan.2024.03.008.","journal-title":"Trends Cancer"},{"issue":"2","key":"10086_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-021-00412-7","volume":"22","author":"KG Yeoh","year":"2022","unstructured":"Yeoh KG, Tan P. Mapping the genomic diaspora of gastric cancer. Nat Rev Cancer. 2022;22(2):71\u201384. https:\/\/doi.org\/10.1038\/s41568-021-00412-7.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10086_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/Biom12081158","volume":"12","author":"SY You","year":"2022","unstructured":"You SY, Su XJ, Ying JJ, Li SP, Qu Y, Mu DZ. Research progress on the role of RNA m6A modification in glial cells in the regulation of neurological diseases. Biomolecules. 2022;12(8):1158. https:\/\/doi.org\/10.3390\/Biom12081158.","journal-title":"Biomolecules"},{"issue":"7","key":"10086_CR85","first-page":"3185","volume":"13","author":"XN Yuan","year":"2023","unstructured":"Yuan XN, Liu Q, Shao YC, Guan XQ, Yang ZL, Chu MF, et al. Mettl3 synergistically regulates TGF-\u03b2\/SMAD2\/3 to promote proliferation and metastasis of gastric cancer. Am J Cancer Res. 2023;13(7):3185\u2013202.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10086_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, et al. Mettl3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1):142. https:\/\/doi.org\/10.1186\/s12943-019-1065-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"10086_CR87","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117. https:\/\/doi.org\/10.1186\/s13045-020-00951-w.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10086_CR88","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.18632\/Aging.103822","volume":"13","author":"FB Zhang","year":"2021","unstructured":"Zhang FB, Yan Y, Cao XG, Zhang JP, Li YX, Guo CQ. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer. Aging-US. 2021;13(8):12224\u201338. https:\/\/doi.org\/10.18632\/Aging.103822.","journal-title":"Aging-US"},{"key":"10086_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126451","author":"HM Zhang","year":"2022","unstructured":"Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, et al. The m6A methyltransferase METTL3-mediated N6-methyladenosine modification of DEK mRNA to promote gastric cancer cell growth and metastasis. Int J Mol Sci. 2022a. https:\/\/doi.org\/10.3390\/ijms23126451.","journal-title":"Int J Mol Sci"},{"key":"10086_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215646","volume":"535","author":"JY Zhang","year":"2022","unstructured":"Zhang JY, Du Y, Gong LP, Shao YT, Pan LJ, Feng ZY, et al. EBV-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3. Cancer Lett. 2022b;535:215646. https:\/\/doi.org\/10.1016\/j.canlet.2022.215646.","journal-title":"Cancer Lett"},{"issue":"1","key":"10086_CR91","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12876-023-02844-x","volume":"23","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Fu J, Zhang Y, Qin X, Wang Y, Xing C. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma. BMC Gastroenterol. 2023;23(1):217. https:\/\/doi.org\/10.1186\/s12876-023-02844-x.","journal-title":"BMC Gastroenterol"},{"key":"10086_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8875424","author":"W Zhou","year":"2021","unstructured":"Zhou W, Xian Q, Wang Q, Wu C, Yan H, Li X, et al. M6A methyltransferase 3 promotes the proliferation and migration of gastric cancer cells through the m6A modification of YAP1. J Oncol. 2021. https:\/\/doi.org\/10.1155\/2021\/8875424.","journal-title":"J Oncol"},{"key":"10086_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-019-1585-2","volume":"10","author":"LY Zhu","year":"2019","unstructured":"Zhu LY, Zhu YR, Han ST, Chen MQ, Song P, Dai DJ, et al. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019;10:383. https:\/\/doi.org\/10.1038\/S41419-019-1585-2.","journal-title":"Cell Death Dis"},{"issue":"1","key":"10086_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188549","volume":"1876","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhu X, Wei X, Tang C, Zhang W. HER2-targeted therapies in gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188549. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188549.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"10086_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1337","volume":"13","author":"L Zhu","year":"2023","unstructured":"Zhu L, Zhu Y, Li F, Meng Y, Wang H, Xu W, et al. Rnautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer. Clin Transl Med. 2023;13(7):e1337. https:\/\/doi.org\/10.1002\/ctm2.1337.","journal-title":"Clin Transl Med"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10086-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10086-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:30:37Z","timestamp":1758875437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10086-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10086"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10086-8","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"132"}}